Fluphenazine Decanoate

Global Calcium is one of the leading manufacturers and exporters of Fluphenazine Decanoate CAS no. 5002-47-1, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.

As manufacturer of Fluphenazine Decanoate we hereby state the following facts about the drug:

Fluphenazine decanoate is the decanoate ester of a trifluoromethyl phenothiazine derivative. It is a highly potent behavior modifier with a markedly extended duration of effect.  Fluphenazine decanoate is usually administered by deep intramuscular (IM) injection into the gluteal region. 

Fluphenazine decanoate has activity at all levels of the central nervous system (CNS) as well as on multiple organ systems. Fluphenazine differs from other phenothiazine derivatives in several respects: it is more potent on a milligram basis, it has a less potentiating effect on CNS depressants and anesthetics than do some of the phenothiazines and appears to be less sedating, and it is less likely than some of the older phenothiazines to produce hypotension.

Indications: Fluphenazine Decanoate Injection is a long ­acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics).

The main suggested advantage of depot antipsychotic medication is that it eradicates covert non?compliance. It is suggested to play a major impact on compliance, which consequently affects and reduces the risk of relapse and hospitalization.

Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market